Wellington Management Group
ARQT icon

Wellington Management Group’s Arcutis Biotherapeutics ARQT Stock Holding History

Wellington Management Group’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
44,373
-1,815
-4% -$46.3K ﹤0.01% 1665
2025
Q4 		$1.34M Sell
46,188
-201
-0.4% -$5.15K ﹤0.01% 1668
2025
Q3 		$874K Buy
46,389
+2,122
+5% +$33.5K ﹤0.01% 1801
2025
Q2 		$621K Sell
44,267
-2,373
-5% -$33.3K ﹤0.01% 1785
2025
Q1 		$729K Sell
46,640
-2,627
-5% -$37K ﹤0.01% 1768
2024
Q4 		$686K Sell
49,267
-3,882
-7% -$42.5K ﹤0.01% 1785
2024
Q3 		$494K Buy
53,149
+923
+2% +$9.11K ﹤0.01% 1818
2024
Q2 		$486K Buy
52,226
+5,679
+12% +$51.4K ﹤0.01% 1782
2024
Q1 		$461K Buy
+46,547
New +$347K ﹤0.01% 1817

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return